Bioceros is a company that specializes in the development of monoclonal antibodies. It offers a suspension CHO platform (CHOBC) that is used to generate cell lines producing proteins ranging from blood proteins and monoclonal antibodies to fusion proteins and enzymes. The company also provides immunoassays, down-stream process development, and full analytical analysis.